← Back to Browse
ProductDiagnostic Tests

Cardiac Risk Assessment Platform

Bundang, South Korea

Platform that evaluates ECG data to identify critical cardiac conditions including shock, respiratory distress, cardiac arrest, and severe electrolyte imbalances requiring emergency intervention. Delivers analysis results in real-time for emergency transport scenarios.

Manufactured by

ARPI, Inc

Bundang, South Korea

ARPI, Inc. is a South Korean medical device company that develops AI-powered ECG analysis software for healthcare applications. The company's flagship product, ECG Buddy, is a Class II medical device approved by MFDS that analyzes 12-lead ECG images to identify 11 major cardiac rhythms and provides risk assessment for 10 digital biomarkers. The software automatically detects ECG regions and delivers rapid interpretation for emergency and clinical settings.

View profile & products →

© 2026 Suplivia · Home · Browse Products